[T-786C endothelial nitric oxide gene polymorphism and type 1 diabetic retinopathy in the Algerian population].

Polymorphisme T-786C de l’eNOS dans la rétinopathie du diabète de type 1 chez la population algérienne.

Journal

Journal francais d'ophtalmologie
ISSN: 1773-0597
Titre abrégé: J Fr Ophtalmol
Pays: France
ID NLM: 7804128

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 23 08 2018
revised: 18 11 2018
accepted: 19 11 2018
pubmed: 10 4 2019
medline: 7 1 2020
entrez: 10 4 2019
Statut: ppublish

Résumé

Diabetic retinopathy (DR) results from interactions between genetic and environmental factors. We were interested in the endothelial nitric oxide gene (eNOS), given the involvement of this enzyme in functional alterations in the retinal microvasculature in diabetes. The goal of our study was to assess the association of T-786C endothelial nitric oxide synthase (eNOS) gene polymorphism with diabetic retinopathy in the Algerian population. Our study enrolled 110 patients with and without DR. All subjects were genotyped for the T786C eNOS polymorphism using the PCR-RFLP method. We also investigated the association between this polymorphism and certain clinical and laboratory characteristics of patients with DR. A significant increase in the frequency of the CC genotype is noted in subjects without DR (P=0.03). We also report a significant increase in the frequencies of the TT+TC genotypes in individuals with DR (P=0.03). However, the association between the different genotypes and clinical or laboratory profiles in patients with DR reveals that the NO level is lower in subjects carrying the TT genotype (P=0.039). Our preliminary results suggest that the CC genotype could confer protection from type 1 diabetic retinopathy in the Algerian population, while the T allele seems to confer susceptibility.

Identifiants

pubmed: 30962068
pii: S0181-5512(19)30118-4
doi: 10.1016/j.jfo.2018.11.014
pii:
doi:

Substances chimiques

Glycated Hemoglobin A 0
hemoglobin A1c protein, human 0
NOS3 protein, human EC 1.14.13.39
Nitric Oxide Synthase Type III EC 1.14.13.39

Types de publication

Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

579-585

Informations de copyright

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Auteurs

E Mihoubi (E)

Équipe cytokines et NO synthases/immunité et pathogénie, laboratoire de biologie cellulaire et moléculaire (LBCM), faculté des sciences biologiques, USTHB, BP 32, El Alia, 16111, Alger, Algérie; Département d'immunologie, institut Pasteur d'Algérie, route du Petit-Staouéli, Delly Brahim, Algérie. Electronic address: esmamih@gmail.com.

F Bouldjennet (F)

Équipe cytokines et NO synthases/immunité et pathogénie, laboratoire de biologie cellulaire et moléculaire (LBCM), faculté des sciences biologiques, USTHB, BP 32, El Alia, 16111, Alger, Algérie; Faculté des sciences, université M'Hamed Bougara de Boumerdès, avenue de l'indépendance, 35000 Boumerdès, Algérie.

R Raache (R)

Équipe cytokines et NO synthases/immunité et pathogénie, laboratoire de biologie cellulaire et moléculaire (LBCM), faculté des sciences biologiques, USTHB, BP 32, El Alia, 16111, Alger, Algérie.

H Amroun (H)

Laboratoire central de biologie. CHU N'fissa Hamoud, Hussein Dey, route de Bachdjerah, el magharia, 16008, Alger, Algérie.

M Azzouz (M)

Service de diabétologie, CHU Mustapha Bacha, Alger, Algérie.

N Benazouz (N)

Service d'ophtalmologie, CHU Beb el Oued, Alger, Algérie.

C Touil-Boukoffa (C)

Équipe cytokines et NO synthases/immunité et pathogénie, laboratoire de biologie cellulaire et moléculaire (LBCM), faculté des sciences biologiques, USTHB, BP 32, El Alia, 16111, Alger, Algérie.

N Attal (N)

Équipe cytokines et NO synthases/immunité et pathogénie, laboratoire de biologie cellulaire et moléculaire (LBCM), faculté des sciences biologiques, USTHB, BP 32, El Alia, 16111, Alger, Algérie.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH